BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3080861)

  • 21. Comparative evaluation of isosorbide-5-mononitrate and nitroglycerin in chronic congestive heart failure.
    Schneeweiss A
    Am J Cardiol; 1988 Mar; 61(9):19E-21E. PubMed ID: 3126632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orally administered isosorbide dinitrate in patients with and without left ventricular failure due to acute myocardial infarction.
    Bussmann WD; Löhner J; Kaltenbach M
    Am J Cardiol; 1977 Jan; 39(1):91-6. PubMed ID: 318796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy.
    Packer M; Meller J; Medina N; Yushak M; Gorlin R
    Circulation; 1981 Sep; 64(3):506-14. PubMed ID: 7261283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitrate therapy for left ventricular failure complicating acute myocardial infarction: a haemodynamic comparison of intravenous, buccal, and transdermal delivery systems.
    Verma SP; Silke B; Reynolds GW; Richmond A; Taylor SH
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):756-62. PubMed ID: 2481190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
    Packer M; Lee WH; Kessler PD; Gottlieb SS; Medina N; Yushak M
    N Engl J Med; 1987 Sep; 317(13):799-804. PubMed ID: 3114637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to isosorbide dinitrate in patients with severe chronic heart failure: incidence and attempt at hemodynamic prediction.
    Kulick D; Roth A; McIntosh N; Rahimtoola SH; Elkayam U
    J Am Coll Cardiol; 1988 Oct; 12(4):1023-8. PubMed ID: 3417975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
    Jordan RA; Seith L; Henry DA; Wilen MM; Franciosa JA
    Circulation; 1985 May; 71(5):980-6. PubMed ID: 3921279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nitrates in the treatment of heart failure].
    Dirschinger J; Hall D; Rudolph W
    Herz; 1990 Jun; 15(3):171-8. PubMed ID: 2115855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.
    Stephens JD; Banim SO; Spurrell RA
    Br Heart J; 1980 Feb; 43(2):220-5. PubMed ID: 7362716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison between the hemodynamic effects of nitroglycerine ointment and oral isosorbide dinitrate in the treatment of left ventricular failure (author's transl)].
    Mauri F; Mafrici A; Azzollini M; Maggiulli G; Domenichini R
    G Ital Cardiol; 1981; 11(12):2070-80. PubMed ID: 6809518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitrate tolerance.
    Parker JO
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitrate tolerance.
    Parker JO
    Am J Cardiol; 1985 Dec; 56(17):28I-31I. PubMed ID: 3934952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vasodilators, oral nitrate derivatives and treatment of heart failure].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(2):139-46. PubMed ID: 825345
    [No Abstract]   [Full Text] [Related]  

  • 35. Sustained beneficial hemodynamic effects of low transdermal nitroglycerin doses compared with placebo in patients with congestive heart failure.
    Bolognese L; Sarasso G; Rognoni G; Makmur J; Fornaro G; Perucca A; Rossi P
    Clin Cardiol; 1988 Feb; 11(2):79-85. PubMed ID: 3126012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
    Abrams J
    Drugs; 1987 Sep; 34(3):391-403. PubMed ID: 3119308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
    Armstrong PW
    J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemodynamic and isotope study of the effects of sublingual and oral administration of isosorbide dinitrate in cardiac insufficiency].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(3):361-77. PubMed ID: 791567
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
    Kubo SH; Fox SC; Prida XE; Cody RJ
    Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.